ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > HTT

HTT

概要

Name:Huntingtin
Target Synonym:Huntingtin,HD protein,HD,HTT,Huntington Disease Protein,IT15,Huntingtin (Huntington Disease),LOMARS,Huntingtin Protein
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 3 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
HTT-H51M5 Human Human HTT Protein, MBP,His Tag (MALS verified)
HTT-H51M5-structure
HTT-H51M5-sds
ACRO Quality

生物活性データの一部

HTT-H51M5-ELISA
HTT MALS images

The purity of Human HTT, MBP,His Tag (Cat. No. HTT-H51M5) is more than 85% and the molecular weight of this protein is around 62-80 kDa verified by SEC-MALS.

Synonym Name

HTT,Htt,Huntingtin

Background

Huntingtin is the protein coded for by the HTT gene. Autosomal dominant mutation in the Huntingtin (Htt) protein is the cause of Huntington’s Disease (HD). In HD, the polyglutamine (polyQ) domain  in the N-terminal sequenceof the protein is expanded beyond a threshold of 36 glutamines. mutant polyQ expansion strongly correlates in an inverse manner to disease age of onset.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
PTC-518 PTC-518 Ptc Therapeutics Inc Huntington Disease Details
Tominersen RG-6042; RO-7234292; ISIS-443139 Phase 3 Clinical Ionis Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd Huntington Disease Details
WVE-003 WVE-003 Phase 2 Clinical Wave Life Sciences Ltd Huntington Disease Details

This web search service is supported by Google Inc.

totopphone